J Korean Surg Soc.
2000 Mar;58(3):412-419.
Surgical Treatment and Prognosis for 268 Patients with Biliary Tract Cancers
- Affiliations
-
- 1Department of Surgery, Inje University College of Medicine and Pusan Paik Hospital, Pusan, Korea.
Abstract
-
PURPOSE: Carcinomas of the biliary tract are considerably rare conditions. In spite of recent progress
in diagnosis and treatment, resectability remains low, and the prognosis is still discouraging. This review
summarizes our 12-year experience with biliary tract cancers, with particular focus on the survival rates
after operation and the prognostic factors that affected the survival of patients. METHODS: Between 1987
and 1998, 268 patients with biliary tract cancers were operated on at our institution. The clinical and
the pathologic data were collected, and a survival analysis was performed. RESULTS: The tumor was
located in the gallbladder in 90 patients, in the proximal bile duct in 74 patients, in the distal bile duct
in 54 patients, and in the ampulla of Vater in 50 patients. One hundred ninety-seven patients underwent
a radical resection (resection rate: 73.5%). A curative resection was achieved in 140 patients (curative
resection rate: 71.1%). The overall operative mortality after resection was 3.0%. The cumulative survival
rates at five years after resection were 61.1% for carcinomas of the gallbladder, 25.8% for proximal
bile duct cancers, 28.9% for distal bile duct cancers, and 48.7% for ampulla of Vater cancers. The
one-year survival rates for the non-resection group were 18.2% and 26.6% for gallbladder cancers and
proximal bile duct cancers, respectively. The mean survival periods for unresectable distal bile duct
cancers and ampullary cancers were 4.7 months and 8.3 months, respectively. Positive lymph-node
metastasis was a statistically significant, poor prognostic factor. CONCLUSION: Long-term survivals can
be expected by a radical surgery for patients with biliary tract cancers. Increasing the resection rate by
performing an extended procedure is essential for the improvement of treatment outcomes.